NCS Multistage (NCSM) Q4 2025 earnings review
Top-Line Beat Driven by U.S. Surge, But 2026 Outlook is Cautious
NCS Multistage delivered a strong Q4, with revenue accelerating 13% YoY to $50.6 million, exceeding prior guidance. However, the headline $5.34 EPS is highly misleading, inflated by a $9.8 million deferred tax valuation allowance reversal; operational earnings (Adjusted Net Income) actually fell to $4.5 million from $6.0 million a year ago. The quarter revealed a massive divergence in segment performance: U.S. revenue surged 69% YoY, while Canada—the company's largest market—reversed course, falling 7%. Management issued a sobering outlook for 2026, projecting lower U.S. customer activity, flat Canadian activity, and structural headwinds from E&P consolidation.
🐂 Bull Case
The U.S. business has completely turned around from a sluggish start to the year, driven by intense demand for Repeat Precision frac plugs and successful integration of the newly acquired ResMetrics tracer business.
Free Cash Flow (less distributions) nearly doubled in FY25 to $18.9 million. The company's asset-light model converts over 70% of Adjusted EBITDA to FCF, resulting in a pristine balance sheet ($36.7M in cash, just $7.6M in debt).
🐻 Bear Case
Canada, historically the company's growth engine, saw revenues decline 7% in Q4. Customer consolidation is reducing pro forma activity levels, which structurally lowers the ceiling for 2026.
Management explicitly warned of a challenging 2026, predicting lower U.S. customer activity and flat Canadian activity. If U.S. market activity declines, NCS's recent U.S. hyper-growth will be very difficult to sustain.
⚖️ Verdict: ⚪
Neutral. NCS Multistage is a fundamentally sound, cash-generating business trading at low multiples, but the top-line growth story is facing severe macroeconomic headwinds in 2026. The Canadian segment's reversal is a significant concern that offsets the U.S. segment's Q4 heroics.
Key Themes
Canadian Growth Engine is Reversing
After printing 19% and 49% YoY revenue growth in Q1 and Q2, the Canadian segment has completely reversed, falling 18% in Q3 and another 7% in Q4 to $27.8 million. Management cited 'softer market conditions' and directly called out customer consolidation in Canada as a headwind that is reducing pro forma activity levels.
U.S. Market Outperformance is Accelerating
The U.S. segment was the sole reason NCS beat Q4 expectations. U.S. revenue accelerated massively, up 69% YoY to $18.1 million. This was driven by a powerful combination of increased Repeat Precision frac plug sales and a $2.8 million contribution from the newly acquired ResMetrics tracer diagnostics business.
Deteriorating 2026 Macro Environment
Management painted a bleak picture for the broader macro environment in 2026, citing commodity prices, trade uncertainty, and strict E&P budget discipline. Specifically, they expect U.S. activity to be 'lower year-over-year' and Canadian activity to be 'relatively flat.' Growth in 2026 will have to come entirely from market share gains rather than rising tides.
Asset-Light Model Drives Cash Generation
NCS's asset-light operating model continues to produce elite cash conversion. Free cash flow after distributions to non-controlling interests accelerated to $18.9 million for the full year, an impressive $9.0 million YoY increase. This funded the strategic cash acquisition of ResMetrics without debt, leaving the company with $36.7 million in cash.
Earnings Quality Distorted by Tax Reversal
The reported GAAP Net Income of $15.0 million (and EPS of $5.34) for Q4 is heavily distorted by a $9.8 million non-cash benefit from reversing a deferred tax valuation allowance. Looking at actual operational profitability, Adjusted Net Income was $4.5 million in Q4 2025, which is actually a deceleration from the $6.0 million generated in Q4 2024. This was partly due to Q4 2024 benefiting from a $1.2 million anomaly in royalty timing.
ResMetrics Integration Progressing Rapidly
The ResMetrics acquisition (closed July 31) has been an immediate accretive driver. It contributed just over $5 million in revenue for its five months in FY25 (beating the high end of guidance), primarily in the U.S. and the Middle East. Management expects full integration milestones to be hit in early 2026, further optimizing the tracer diagnostics product line.
Other KPIs
Stable. Flat year-over-year. While overall margins remained steady, Gross Margin actually ticked down slightly to 40% from 42% last year due to product and service mix, specifically within international tracer diagnostics.
Decelerating. SG&A decreased from $15.0 million in Q4 2024, an impressive feat considering it includes an additional $0.6 million from the ResMetrics acquisition. The reduction was driven by lower annual incentive bonus accruals and reduced professional fees.
Stable. Grew 5% year-over-year. Product revenues increased due to higher fracturing systems sales in the North Sea and well construction in the Middle East. However, service revenues declined because several large tracer diagnostic projects completed in Q4 2024 did not recur at the same level.
Guidance
Decelerating. Management explicitly states U.S. market activity will decline due to macro factors and commodity prices. This sets up a challenging environment for NCS's U.S. segment to repeat its 2025 growth, requiring significant market share capture.
Stable to Decelerating. Following a year of extreme volatility in the Canadian rig count and E&P activity, management is planning for a flat market. Furthermore, they note that 'customer consolidation' in Canada has reduced pro forma activity levels, acting as a direct headwind.
Accelerating. The only geography where management expects aggregate customer activity to increase. However, the timing is explicitly weighted to the second half of the year, particularly in the Middle East.
Key Questions
Canada Market Share vs Macro
Canada segment revenues fell 7% YoY in Q4, and you called out customer consolidation reducing pro forma activity. Does this represent a structural reset in your Canadian market share ceiling, or is it a temporary lull while consolidated operators finalize their 2026 plans?
Sustaining U.S. Growth
U.S. revenue surged 69% in Q4, yet your 2026 outlook expects lower U.S. industry activity year-over-year. How much of Q4's U.S. strength is sustainable through Repeat Precision market share gains versus one-off sales or initial ResMetrics stocking?
Capital Allocation Strategy
You ended 2025 with nearly $37 million in cash and generated $19 million in free cash flow. Given the cautious outlook for North American activity in 2026, will excess cash be directed more toward additional M&A, or will you consider programmatic shareholder returns like buybacks?